Skip to content

MAPIALEJ

Active Private limited companyfounded 2019active for 7 yearsDrogenberg 20A, 3090 OverijseKBO/BCE: BE 0729.570.751

Lifetime

6 annual accounts with figures on one time axis
peak €326,552 (2025)
€326,552▲ 23.4%
peak €258,584 (2025)
€258,584▲ 41.9%
peak €1,500 (2020)
€1,500unchanged
€430,739▲ 52.7%
Board1 name since 2019
Documentsfilings and deeds
10-10-2026163 days late
2025micro format
Gross margin from €264,622 to €326,552Result from €182,233 to €258,584Dividend €258,584Debts from €282,079 to €430,739Cash from €64,026 to €106,933

Key points

from the 2025 annual accounts

Equity

€1,500 =
1,5002024+258,584Profit-258,584Dividend1,5002025

MAPIALEJ paid out €258,584 in dividends. That is 100% of the 2025 profit.

Result

€258,584 ▲ 41.9%
€182,0002024€259,0002025

The result rose in 2025 from €182,233 to €258,584.

Debts

€430,739 100% of the balance sheet
Financial debts 10%Suppliers 18%Taxes and wages 5%Other 67%

Of this, €386,898 falls due within a year.

Investments

€24,821 2.2 × depreciation
2022202320242025

Green is investment, beige is depreciation. Machinery stands 465.3% higher than in 2024.

Filings

6 annual accounts 163 days
deadline202020222024

Latest accounts filed late: after the legal deadline.

Position in the sector

0.3%

Lower solvency than 95% of companies in human health. Sector median 63.0% · 20,767 companies.

Checked score

54
Fair
Financially stronger than 32% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%

A confirmed filing finding caps the score at 59.

Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: < 0.1%▼ -0.1 percentage points vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: 0.1%▲ +0.1 percentage points vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: < 0.1%▼ -0.1 percentage points vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.4%▲ +0.4 percentage points vs 09-2026highest value 11-2026: 0.4%● unchanged vs 10-2026highest value

Financial strength
Average

25-1equity 0.3% of total assets
31+3short-term debt 89.5% · cash 24.7%
100=return on assets 59.8%

Score breakdown

raises risk
Capped at 59: a confirmed filing finding
Last filed accounts filed 163 days late; 1 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 0.89, cash €106,933
Figures for financial year 2025 (filed on 18-10-2026)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 4% of them on solvency, 6% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-09-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 2,153 companies had the same profile as MAPIALEJ has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.2%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of MAPIALEJ itself: 0.4% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,153 companies, not a prediction for MAPIALEJ. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

No publishable credit limit, so credit only on tighter terms

Liquidity is insufficient, with a current ratio of 0.89 (0.5 in 2024), below 1. Short-term debt is 89.5% and cash 24.7% of total assets. 99.7% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Last filed accounts filed 163 days late; 1 of the last 3 accounts late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.89, cash €106,933
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 18-10-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20767 sector peers (2025).
NBB · sector comparison
Position among 20767 sector peers
Solvency
better than 5%
← weakest strongest →
raises risk · 2025 accounts filed 163 days late
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 10-10-2026, 163 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 6 filings
Deviation from the deadline
2025
163 days late
2024
36 days early
2023
12 days early
2022
41 days early
2021
40 days early
2020
32 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average on the deadline day. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 25 March (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end10-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

FV
Director, since 27-06-2019
  • FERNANDEZ VILLARREAL Wendy 100 sharesdeed of 02-07-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0729570751
Amendment of the articles Gazette deed
Registered office moved from Beauvechain to Overijse New registered office: Drogenberg 20A, 3090 Overijse · Previous registered office: Le Petit Champ, Nodebais 2, 1320 Beauvechain · Gazette deed
Incorporation Founding capital of €1,500, 100 shares · Founder: FERNANDEZ VILLARREAL Wendy · Appointment: FERNANDEZ VILLARREAL Wendy (director) · published on 02-07-2019 · Gazette deed
All 12 events

Comparable companies

same main activity, similar in size and age
Company
MAPIALEJ Overijse €432,239 €326,552 0.3% -
Anesthésie-Réanimation / Soins Intensifs Docteur Damien Henrard Wasseiges €444,719 €326,074 26.8% -
Dr. Eno Lavrysen Neurochirurgie Mortsel €413,674 €344,491 53.5% -
Nsthesiology Stoumont €457,832 €319,380 67.9% -
DR. JEROEN HUYS, ANESTHESIE-REANIMATIE Destelbergen €446,424 €302,852 9.2% -
DR. K. LEFEBVRE Sint-Niklaas €388,307 €327,263 0.5% -
Dr. Christophe Breusegem Lievegem €463,170 €308,878 5.9% -

These companies have the same main activity as MAPIALEJ: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €388,000 and €463,000, founded between 2018 and 2020.

Official details

Source: KBO
Status
Active since 28-06-2019Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.293.142.8511320 Beauvechain, since 28-06-2019
Financial year end
30 September
Peppol
Reachable since 24-06-2025
Company details

Annual accounts to 30-09-2025

≈ €500,000estimated
€432,239▲ 52.4%
Filing
Filed on 10-10-2026
Financials

Insights on MAPIALEJ

MAPIALEJ files the micro format. That format states no turnover. The gross margin rose from €82,519 in 2020 to €326,552 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MAPIALEJ

What is the company number of MAPIALEJ?
The company number of MAPIALEJ is 0729.570.751. The VAT number is the same number with BE in front: BE 0729.570.751.
Where is MAPIALEJ based?
The registered office is at Drogenberg 20A, 3090 Overijse.Company details
What does MAPIALEJ do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MAPIALEJ?
MAPIALEJ is a private limited company (BV).
When was MAPIALEJ founded?
MAPIALEJ was founded on 28-06-2019.
Is MAPIALEJ still active?
Yes, MAPIALEJ is an active enterprise in the KBO register.
What is the turnover of MAPIALEJ?
The turnover in financial year 2025 is ≈ €500,000. This figure is estimated from the gross margin of €326,552 and 30 comparable companies (NACE 86220). It probably lies between €440,000 and €680,000.Financials
Is MAPIALEJ profitable?
In financial year 2025, MAPIALEJ made a profit of €258,584.
Where can I find the annual accounts of MAPIALEJ?
MAPIALEJ filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MAPIALEJ due?
MAPIALEJ must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.